NASDAQ •
Healthcare •
Biotechnology •
Quote as of 07/07/2026 16:00
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization3,228.4 mln
Float92.57 mln
Earnings Date07/30/2026
Piotroski F-Score
5
/ 9
Neutral
Beneish M-Score
-1.98
Caution advised
Relative Strength
75
/ 100
Strongly outperforming
Debt / Equity
0.61
Moderate leverage
Pre-Tax Margin
1%
Break-even
ROE
-1.45
Negative
Business Description
Arcutis Biotherapeutics is a California-based company founded in 2016 that researches and brings to market new medicines for skin conditions. Its flagship product, ZORYVE, is available as both a cream and a foam to treat conditions such as plaque psoriasis, atopic dermatitis, and seborrheic dermatitis. The company is also working on an experimental treatment called ARQ-234, which targets the immune system to address skin disease in a novel way.
